Last updated on October 2018

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)


Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Contact Investigators or Research Sites near you

Start Over

US GSK Clinical Trials Call ...

GSK Investigational Site
National City, CA United States
0.6miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Chula Vista, CA United States
3.38miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
La Mesa, CA United States
8.65miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
San Diego, CA United States
9.22miles
  Connect »